Curriculum Vitae Lorenzo P. Moja MD, MSc, Dr Pub Health, PhD
November 2017
Offices Department of Biomedical Sciences for Policy, Access and Use (PAU) Health, University of Milan Essential Medicines and Health Products Dipartimento di Scienze Biomediche per la Department (EMP) Salute World Health Organization Università degli Studi di Milano 20, avenue Appia Via Carlo Pascal, 36 1211 Geneva 20133 Milano Switzerland
Tel: +390250315097 Tel: +41227913756 E-mail: [email protected] E-mail: [email protected]
Clinical Epidemiology Unit, IRCCS Orthopaedic Institute Galeazzi Unità di Epidemiologia Clinica IRCCS Istituto Ortopedico Galeazzi Via Riccardo Galeazzi, 4 20161 Milano
E-mail: [email protected]
Actual Professional Appointments
2015 Technical Officer, Policy, Access and Use (PAU), Essential Medicines and Health Products Department (EMP), Headquarter World Health Organization
2011 Assistant Professor (on leave), Department of Biomedical Sciences for Health, University of Milan, Milan
2012 Head, Clinical Epidemiology Unit (on leave), IRCCS Orthopedic Institute Galeazzi, Milan
1 Biography
In 2000 Dr Moja (b. Milan, 1974) obtained his medical degree from University of Milan (Italy). After medical school he completed a Master Program in Systematic Reviews and Evidence Syntheses. He spent a training period as Research Fellow at the Epidemiology Program in Ottawa (Canada), where the Editorial Base of the Cochrane Effective Practice and Organisation of Care (EPOC) review group was based. During his stay (2003-2004) Dr. Moja was trained in epidemiology, knowledge transfer and health services research with special reference to the methodology of systematic reviews and clinical trials. In 2004 he completed the medical specialty of Hygiene, Preventive and Community Medicine from the University of Milan. In 2014 he gained a Doctorate (D Phil) from Open University (UK), researching into strategies for success of competency-based Continuous Medical Education (CME) programs for medical doctors.
In 2005 Dr Moja joined the staff of the Cochrane Collaboration. He was the Deputy-Director of the Italian Cochrane Centre in Milan from 2007 to 2011. He has been scientist and research manager for various projects at the Mario Negri for Pharmaceutical Research (2005-2011) focusing on drug evaluations, from animal studies to phase IV trials. Since 2011 he has been Assistant Professor of Public Health at the University of Milan. In 2012 he started the Clinical Epidemiology Unit at the Galeazzi Orthopedic Institute, a research unit to improve the quality of scientific studies in physical therapy and beyond.
In 2015 Dr Moja joined the Department of Essential Medicines and Health Products of the World Health Organization (WHO). He serves as technical officer at the Secretariat of the Model List of Essential Medicines (EML), a global standard to guide countries in identifying medicines that should be not only widely available in national health care systems, but also affordable to individuals and the community. It is used by all UN organizations and by more than 150 countries, where it forms the basis for coverage-program formularies and national EMLs.
Dr Moja is a member of various steering groups and advisory committees related to research & innovation. Among the others he participated in the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Group and is actively involved in the GRADE Working Group. He is a member of the WHO Guideline Review Committee, reviewing guideline development. He was part of the UniMiVal (2012-2015), a group of young researchers supporting the evaluation board of Milan University in assessing the quality of all PhD courses, with the goal of improving postgraduate education, and of the executive board of the Associazione Alessandro Liberati – Italian Cochrane Network (2012-2015).
Dr Moja is a senior clinical editor of Internal and Emergency Medicine, the official journal of the Italian Society of Internal Medicine (in the period 2008-2013 he was Deputy Editor). He is Editor of the Dr Cochrane, an innovative online Continuing Professional Education Development product that embeds evidence from Cochrane reviews into a vignette based narrative. He is editor of several CME courses for medical doctors.
Dr Moja is a member of the PhD program in Epidemiology, Environment and Public Health at the University of Milan. He managed several academic activities, including unit’s finances and grants, overseeing academic and administrative operations for postgraduate courses.
Dr Moja has published over 100 peer reviewed papers and editorials, book chapters and commentaries. One fifth of his scientific articles were published in top-ranked medical journals (Annals of Internal Medicine, BMJ, Cochrane, JAMA, PLOS Medicine). He authored several reviews on biotechnology medicines that offered the basis of reimbursement decisions at national health
2 systems. He has been commissioned the development of innovative strategies to better support health policy makers around the world in making evidence-informed decisions. His scientific works have been cited thousands of times.
Dr Moja is the recipient of several national and international grants. He is one of the very few Italian researchers receiving two young investigator awards (2009 and 2012) from the Minister of Health.
Research and Health-System Interests
Dr. Moja worked in the fields of evidence-based medicine, clinical investigation, experimental and observational epidemiology, research methodology, health systems research, and innovative models to promote the quality and efficiency of clinical decisions.
His research is concentrated in a few themes. Dr Moja has an interest in solving questions that clinicians face in their practice synthetizing evidence. He developed systematic reviews and meta-analyses of medical interventions across several medical specialties - autoimmune diseases, cardiology, neurology, oncology, orthopaedics, palliative medicine, paediatrics, physiotherapy, surgery, and rare diseases. He is author of several Cochrane, non-Cochrane reviews and clinical guidelines focused on both efficacy and safety of therapies, including innovative biotech medicines. His reviews on trastuzumab for breast cancer and bevacizumab for macular degeneration served as basis for coverage decisions in several countries. A second area of work relates to methodology. He has undertaken research on: a) the design, conduct and analysis of experimental studies in animals and humans; b) the risk of bias and validity of primary studies and systematic reviews; c) the transparent and accurate reporting of research; and d) how to handle scientific disputes across experts and guideline panels, using consensual methods such as the GRADE. Dr Moja has experience in the area of knowledge transfer adopting new media technologies (i.e. e- learning, point-of-care information services and computer decision support systems) and communication strategies (i.e. different format of evidence). He conducted studies to explore the effectiveness of different knowledge transfer intervention for doctors, specialists and patients. He had evaluated a wide range of point-of-care services (e.g. Clinical Evidence, UpToDate, ACP Pier, eTG and Dynamed) for their editorial and evidence-based quality. He is the principal investigator of two large randomized controlled trials to assess the impact of computer decision support systems in general and specialty hospitals. The fourth focus is on health and research policies to ensure optimal payback from public and private investments. He studies how governments, international agencies like the WHO and donors (research foundations), evaluate complex portfolio of innovations and health care programs and determine whether the right mix of highly-effective medicines and services get to those who need them, at an acceptable cost. The research supports health system policymakers and stakeholders around the world in taking advantage of the best available research evidence, including studies other than randomized controlled trials. Context, institutional constraints, interest group pressures, values and other factors that drive the policymaking process are analysed to set agendas, take well- considered actions and communicate the rationale for actions effectively.
3 Education background and qualifications
May 2014 DPhil – Open University, UK Affiliated Research Centre Programme: Mario Negri Institute for Pharmacological Research, Milan Topic: E-learning Programs Based in High Quality Evidence to Transfer Knowledge and to Improve Practice for Health Care Professionals Supervisors: Prof. Alessandro Liberati, Dr. Jeremy Grimshaw Support: Mario Negri Institute for Pharmacological Research
November 2011 Post-graduate courses in “Statistics applied to clinical questions”, School of Medicine, University of Modena and Reggio Emilia, Modena Supervisor: Prof. Roberto D’Amico
November 2004 Specialty in Hygiene, Preventive and Community Medicine (duration 4 years), Medical School, University of Milan, Milan Thesis: Strutture di diagnosi e ricovero alternative per pazienti con ictus cerebrale acuto: valutazione delle opportunità di un’analisi costi-efficacia e costi-utilità affiancate al trial clinico PROSIT [Alternative strategies for stroke care in Italy: exploring cost- effectiveness and cost-utility analyses from a prospective, observational study (PROSIT)] Supervisor thesis: Prof. Vittorio Mapelli, Prof.ssa Livia Candelise Supervisor medical activities: Prof. Francesco Auxilia
April 2004 Post-graduate courses in “Epidemiology I” “Biostatistic I” “Economic Evaluation in Health Care” and “Quantitative Methods”, University of Ottawa, Ottawa
March 2002 Post-graduate course in “Evidence Based Medicine”, School of Medicine, University of Modena and Reggio Emilia, Modena Supervisor: Prof. Alessandro Liberati
February 2002 Master of Science (Medical School) Systematic Reviews in Health Care Medical School, University of Milan, Milan Supervisor: Prof. Alessandro Liberati
October 2000 Medical Degree, cum laude [110/110 with honours] Medical School, University of Milan, Milan Thesis: Analisi della tipologia delle linee-guida adottate in un ospedale di insegnamento e valutazione delle attitudini dei medici mediante indagine questionario [Analysis of some variables concerning guidelines adopted in a Hospital in Milan: quantity, quality and physicians’ attitude. Which is the reciprocal influence of these factors?] Supervisor: Prof. Francesco Auxilia
4 Past Professional appointments
2007 - 2011 Deputy-Director, Italian Cochrane Centre at Mario Negri Institute for Pharmacological Research, Milan
2004 - 2008 Research fellow at Italian Cochrane Centre at Mario Negri Institute for Pharmacological Research, Milan
2003-2004 Research Fellow at Cochrane Effective Practice and Organization of Care Group, Institute of Population Health, University of Ottawa, Ottawa
2001-2003 Research assistant at Italian Cochrane Centre at Mario Negri Institute for Pharmacological Research, Milan
Membership of professional bodies
2001 - on College of Physicians of Milan, Italy (Subscription No. 37282)
Professional affiliations
2001 - on Member of AREAS – Associazione per la Ricerca sull’Efficacia dell’Assistenza Sanitaria
2003 - on Charter Member of AREAS II - Associazione per la Ricerca sull’Efficacia dell’Assistenza Sanitaria II
2009 - 2015 Member of SItI – Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica
Honours and awards
February 2003 Progetto Professionalità – Fondazione Bancaria Monte di Lombardia – Merit post-graduate scholarship (€ 26.000 / year)
August 2002 “Thomas Chalmers” 2002 Award – 10° Cochrane Colloquium, Stavanger, Norway (2 classified)
October 2001 “Dedalo 2001” Award - Panorama Sanità (1 classified, € 750)
Research grants awarded
2017 – 2019 Bando per “L’individuazione di un soggetto terzo che utilizzi l’Evidence to Decision (ETD) Framework per lo svolgimento di un’istruttoria completa su determinati vaccini – Dgr n. 4850 del 17.12.2015” Role: Principal Investigator Funder: Regione Lombardia Amount: € 109.000 Lenght: 24 months
5
2016 – 2018 Bando Ricerca applicata in campo medico 2015/2016 Fondazione Carispezia: “METODO GRADE: aumentare la qualità delle cure dei pazienti sostenendo l'evidence based practice”. Role: Co-investigator Funder: Fondazione Carispezia Amount: € 69.536 Date: May 2016 Lenght: 24 months
2014 – 2017 Bando GR 2011-12 Young Research Award: GRADE - Dispute. Improving appropriateness and transparency of processes to develop guidelines on controversial clinical areas: evidence, values and context preferences to help mitigate disputes and enhance the applicability of recommendations to practice Role: Principal Investigator Funder: Italian Ministry of Health ID Number: GR‐2011‐02348048 Amount: € 688.00,00 Date: December 2014 Length: 36 months
2013 – 2016 Conto capitale: Televalutazione e teleriabilitazione per la prevenzione del rischio cadute – Tele-rehabilitation to prevent falls in elderly people Role: Principal Investigator ID Number: - Funder: Italian Ministry of Health Amount: € 259.000 Date: December 2012 Length: 36 months
2012 - 2013 Modello decisionale per l’adozione / modifica dell’offerta vaccinale nella Regione Lombardia - Decision Support for Vaccination Policies: an Overview of Systematic Reviews Role: Principal Investigator ID Number: - Funder: Lombardia Region Amount: € 53.000,00 Date: December 2012 Length: 18 months
2011 - 2015 Bando 2009 Young Research Award: Effect on professional practice and health care outcomes of computerized evidence‐based information system and clinical decision support: a randomized controlled trial in orthopaedics Role: Principal Investigator: Funder: Italian Ministry of Health ID Number: GR‐2009‐160673 Amount: € 287.188,00 (50% of € 574.376,00) Date: December 2011 Length: 48 months
6
Co-Funder: Lombardia Region ID Number: GR‐2009‐160673 Amount: € 287.188,00 (50% of € 574.376,00) Date: December 2012 Length: 36 months
2011 – 2012 Dr Cochrane: developing online learning modules from Cochrane reviews. Role: Investigator Research Net ID: 119470 Funder: Canadian Institutes of Health Research Amount: Can $ 100.000 Date: July 2011 Length: 12 months
2009 – 2010 Efficacy, toxicity, duration and modalities of administration of anti-HER2 agents in HER-2 positive breast cancer: a prospective systematic review. Principal investigator: Roberto D’Amico Role: Investigator ID Number: FARM7C4AFN Length of time: 24 months Funder: AIFA – Italian Medicines Agency Amount: € 60.000 Date: December 2008
2007 – 2009 ECCE Medici – Gestione piattaforma di E-learning basata sui contenuti Clinical Evidence e attività di sperimentazione relative (soddisfazione e efficacia nel trasferimento di conoscenze) Role: Investigator ID Number: contratto LOTTO 1 ECCE Medici REP n. 02/2007 del 20/09/07 aggiudicazione del 26/07/07 prot. AIFA/78536/F.3 Funder: AIFA – Italian Medicines Agency Amount: € 716.000 Date: July 2007 Length: 30 months
2007 – 2009 Monitoring innovations in the field of anticancer drugs: an integrated model of technology assessment (systematic reviews, production, implementation and evaluation of clinical recommendations) based on the collaboration among regions and between regions and national agencies (ASSR and AIFA) of the Italian National Health Service. Role: Investigator, work-package leader ID Number: Year 2006 prot. 01-RFPS-2006-5-341291 Length of time: 24 months Funder: Italian Ministry of Health Amount: € 2.414.000 Date: October 2007
7 2007 – 2008 Acquisizione dei diritti di traduzione; traduzione; stampa e spedizione; aggiornamento on-line del volume Clinical Evidence n.6. [Licence of translation rights, translation and adaption, publication and distribution; on-line up date of the Italian Edition of Clinical Evidence VI edition] Role: Coordinator Funder: AIFA – Italian Medicines Agency Amount: € 776.040 Date: November 2007 Length: 8 months
2006 – 2007 Clinical Evidence Continuous Medical Education: randomised educational trial of an e-learning program for transferring evidence based information in primary care – ICEKUBE (Italian Clinical Evidence Knowledge Utilization Behaviour Evaluation) Role: Investigator ID Number: prot. AIFA/IC/16405/F.3a del 15-2-2007 - prosecuzione: contratto LOTTO 1 ECCE Medici REP n. 02/2007 del 20/09/07 Length of time: 24 months Funder: AIFA – Italian Medicines Agency Amount: € 96.000 Date: May 2006
2006 – 2007 COFIN Programma di ricerca interuniversitario - A USERS' GUIDE ON DISCORDANT SYSTEMATIC REVIEWS: un programma di ricerca mirato a mettere a punto uno strumento per la valutazione della validità scientifica e riproducibilità delle revisioni sistematiche di letteratura e del loro impatto sulle raccomandazioni per la pratica clinica (linee guida) in campo oncologico, neurologico, cardiologico, odontoiatrico e di valutazione economica degli interventi sanitari. [Interuniversity Research Programme – A USERS' GUIDE ON DISCORDANT SYSTEMATIC REVIEWS: a research program aimed at producing a practical tool to assess the validity and reliability of systematic reviews and their impact on practice guidelines in oncology, neurology, cardiology, oral health and economic evaluation of health care interventions] Role: Investigator ID Number: Year 2006 - prot. 2006062298 Lenght of time: 24 months Funder: MIUR – Italian Ministry of Education, University and Research Amount: € 304,900 Date: March 2006
2002 – 2004 Programma di ricerca interuniversitario - Valutazione della qualità degli studi primari nelle revisioni sistematiche di letteratura: ricadute della loro metodologia per l'insegnamento dell'Evidence Based Medicine. [Interuniversity Research Programme – Quality assessment of primary studies in systematic reviews: implications of their methodology for the teaching of Evidence Based Medicine]. Role: Investigator ID Number: Year 2002 prot. 2002061749_001 Length of time: 24 months
8 Funder: MIUR - Italian Ministry of Education, University and Research (COFIN) Amount: € 116.000 Date: November 2002
2004 Traduzione e adattamento, progetto grafico, stampa distribuzione del volume Clinical Evidence (III ed.). [Translation and adaptation, graphical project, publication and distribution of the Italian Edition of Clinical Evidence (III Edition)] Role: Coordinator Date: 2004, April Length of time: 12 months Funder: Italian Ministry of Health Amount: € 640.040
2004 Progetto ECCE – Sperimentazione formazione a distanza attraverso l’Educazione Continua in Medicina via internet basato sui contenuti di Clinical Evidence [ECCE Project - Evidence based knowledge driven by Clinical Evidence through an Italian continuing education program on the web: evaluation of ECCE] Role: Coordinator Date: 2004, June Length of time: 18 months Funder: Zadig Publisher Amount: € 120.000
2002 Traduzione e adattamento, progetto grafico, stampa distribuzione del volume Clinical Evidence (II ed.). [Translation and adaptation, graphical project, publication and distribution of the Italian Edition of Clinical Evidence (II Edition)] Role: Coordinator Date: 2002, 28 May Length of time: 11 months Funder: Italian Ministry of Health Amount: € 1.953.735
2001 Traduzione e adattamento, progetto grafico, stampa distribuzione del volume Clinical Evidence. [Translation and adaptation, graphical project, publication and distribution of the Italian Edition of Clinical Evidence] Role: Coordinator Date: 2000, 21 December Length of time: 10 months Funder: Ministero della Sanità – Dipartimento per la valutazione dei medicinali e la farmacovigilanza Amount: € 770.000
Dr Moja also received grants from philanthropy donors. Among them, the Cochrane Collaboration funded some Cochrane Systematic Reviews through the NIHR Cochrane Review Incentive Awards, the Mario Negri Institute for Pharmacological Research supported some
9 research and dissemination activities when the research pipeline was still in its infancy, and the IRCCS Orthopedic Galeazzi Institute helped to launch the Clinical Epidemiology Unit supporting daily activities and staff. Among medical publishers, AboutPharma, Medilogy, Wiley-Blackwell and Springer funded some activities associated with the development of research or products in which there was a mutual interest. Most of these grants were small, rarely consisting of more than 10.000€ per year per single source. Nevertheless they were tremendously important because they allowed realizing special projects or covered start up periods.
Publications
Impact of publications since 2003
Scopus (Author ID:8412179000 Moja Lorenzo P.) - Assessed November 2017 Number of indexed publications 141 Citations 15747 h-index: 26
Google scholar (Lorenzo Moja GOOGLE Scholar Page) - Assessed November 2017 Citations 45868 h-index: 31 i10-index: 73
Peer-reviewed journals
1. World Health Organization. The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO model list of essential medicines and the 6th WHO model list of essential medicines for children). WHO technical report series; no.1006. World Health Organization. 2017. ISBN 978-92-4-121015-7
2. Morgano GP, Amato L, Parmelli E, Moja L, Davoli M, Schünemann H. [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] Recenti Prog Med. 2017 Oct;108(10):402-424. doi: 10.1701/2802.28354. Italian. PMID: 29105695
3. World Health Organization. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. Guideline. World Health Organization. Sep 2017. ISBN: 978-92-4-155011-6
4. World Health Organization. Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis. World Health Organization. Sep 2017.
10 5. World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. World Health Organization. Sep 2017.
6. Liberati EG, Ruggiero F, Galuppo L, Gorli M, González-Lorenzo M, Maraldi M, Ruggieri P, Polo Friz H, Scaratti G, Kwag KH, Vespignani R, Moja L. What hinders the uptake of computerized decision support systems in hospitals? A qualitative study and framework for implementation. Implement Sci. 2017 Sep 15;12(1):113. doi: 10.1186/s13012-017-0644-2.
7. Pottie K, Welch V, Morton R, Akl EA, Eslava-Schmalbach JH, Katikireddi V, Singh J, Moja L, Lang E, Magrini N, Thabane L, Stanev R, Matovinovic E, Snellman A, Briel M, Shea B, Tugwell P, Schunemann H, Guyatt G, Alonso-Coello P. GRADE equity guidelines 4: guidance on how to assess and address health equity within the evidence to decision process. J Clin Epidemiol. 2017 Aug 10. pii: S0895-4356(17)30895-8. doi: 10.1016/j.jclinepi.2017.08.001. [Epub ahead of print]
8. Elias C, Moja L, Mertz D, Loeb M, Forte G, Magrini N. Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open. 2017 Jul 26;7(7):e016264. doi: 10.1136/bmjopen-2017-016264. . 9. Bruschettini M, O'Donnell CP, Davis PG, Morley CJ, Moja L, Zappettini S, Calevo MG. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Cochrane Database Syst Rev. 2017 Jul 14;7:CD004953. doi: 10.1002/14651858.CD004953.pub3. Review.
10. Schandelmaier S, Tomonaga Y, Bassler D, Meerpohl JJ, von Elm E, You JJ, Bluemle A, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Stegert M, Olu KK, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Guyatt G, Bucher HC, Kasenda B, Briel M. Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study. J Pediatr. 2017 May;184:209-214.e1. doi: 10.1016/j.jpeds.2017.01.071. Epub 2017 Mar 3.
11. Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, Senni M, Clemenza F, Agnese V, Falletta C, Romano G, Maalouf J, Dandel M. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. 2017 Jul;19(7):926-946. doi: 10.1002/ejhf.733. Epub 2017 Mar 31. Review.
12. Bonovas S, Minozzi S, Lytras T, González-Lorenzo M, Pecoraro V, Colombo S, Polloni I, Moja L, Cinquini M, Marino V, Goletti D, Matucci A, Tocci G, Milano GM, Scarpa R, Cantini F. Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic reviewand meta-analysis. Expert Opin Drug Saf. 2016 Dec;15(sup1):35-54. Review. [I.F. 2.896]
13. Minozzi S, Bonovas S, Lytras T, Pecoraro V, González-Lorenzo M, Bastiampillai AJ, Gabrielli EM, Lonati AC, Moja L, Cinquini M, Marino V, Matucci A, Milano GM, Tocci G, Scarpa R, Goletti D, Cantini F. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34. Review. [I.F. 2.896]
11 14. Gianola S, Frigerio P, Agostini M, Bolotta R, Castellini G, Corbetta D, Gasparini M, Gozzer P, Guariento E, Li LC, Pecoraro V, Sirtori V, Turolla A, Andreano A, Moja L. Completeness of Outcomes Description Reported in Low Back Pain Rehabilitation Interventions: A Survey of 185 Randomized Trials. Physiother Can. 2016;68(3):267-274. [I.F. 0.614]
15. Moja L, Passardi A, Capobussi M, Banzi R, Ruggiero F, Kwag K, Liberati EG, Mangia M, Kunnamo I, Cinquini M, Vespignani R, Colamartini A, Di Iorio V, Massa I, González-Lorenzo M, Bertizzolo L, Nyberg P, Grimshaw J, Bonovas S, Nanni O. Implementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients: the ONCO-CODES study protocol for a randomized controlled trial. Implement Sci. 2016 Nov 25;11(1):153. [I.F. 3.201]
16. Capobussi M, Banzi R, Moja L, Bonovas S, González-Lorenzo M, Liberati EG, Polo Friz H, Nanni O, Mangia M, Ruggiero F. [Computerized decision support systems: EBM at the bedside]. Recenti Prog Med. 2016 Nov;107(11):589-591.
17. Banzi R, González-Lorenzo M, Kwag KH, Bonovas S, Moja L. [The added value of information summaries supporting clinical decisions at the point-of-care.]. Recenti Prog Med. 2016 Nov;107(11):582-585.
18. Biagioli E, Tarasco V, Lingua C, Moja L, Savino F. Pain-relieving agents for infantile colic. Cochrane Database Syst Rev. 2016 Sep 16;9:CD009999. [Epub ahead of print] Review. [I.F. 6.103]
19. Castellini G, Gianola S, Banfi G, Bonovas S, Moja L. Mechanical Low Back Pain: Secular Trend and Intervention Topics of Randomized Controlled Trials. Physiother Can. 2016;68(1):61-3. [I.F. 0.614]
20. Moja L, Polo Friz H, Capobussi M, Kwag K, Banzi R, Ruggiero F, González-Lorenzo M, Liberati EG, Mangia M, Nyberg P, Kunnamo I, Cimminiello C, Vighi G, Grimshaw J, Bonovas S. Implementing an evidence-based computerized decision support system to improve patient care in a general hospital: the CODES study protocol for a randomized controlled trial. Implement Sci. 2016 Jul 7;11(1):89. [I.F. 3.201]
21. Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS Med. 2016 Jun 28;13(6):e1002046. [I.F. 13.585]
22. Rocco N, Rispoli C, Moja L, Amato B, Iannone L, Testa S, Spano A, Catanuto G, Accurso A, Nava MB. Different types of implants for reconstructive breast surgery. Cochrane Database Syst Rev. 2016 May 16;(5):CD010895. [I.F. 6.103]
23. Castellini G, Gianola S, Bonovas S, Moja L. Improving Power and Sample Size Calculation in Rehabilitation Trial Reports: A Methodological Assessment. Arch Phys Med Rehabil. 2016 Mar 10. pii: S0003-9993(16)00152-0. [Epub ahead of print] [I.F. 3.045]
12 24. Bruschettini M, Zappettini S, Moja L, Calevo MG. Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns. Cochrane Database Syst Rev. 2016 7;3:CD011493. [I.F. 6.103]
25. Gianola S, Castellini G, Agostini M, Bolotta R, Corbetta D, Frigerio P, Gasparini M, Gozzer P, Guariento E, Li LC, Pecoraro V, Sirtori V, Turolla A, Andreano A, Moja L. Reporting of Rehabilitation Intervention for Low Back Pain in Randomized Controlled Trials: Is the Treatment Fully Replicable? Spine (Phila Pa 1976). 2016;41(5):412-8. [I.F. 2.439]
26. González-Lorenzo M, Tirani M, Piatti A, Coppola L, Gramegna M, Ruggiero F, Auxilia F, Moja L. [Decisional framework for varicella vaccine: challenges in the face of opportunity]. Recenti Prog Med. 2016 Feb;107(2):84-107.
27. Kwag KH, González-Lorenzo M, Banzi R, Bonovas S, Moja L. Providing Doctors With High- Quality Information: An Updated Evaluation of Web-Based Point-of-Care Information Summaries. J Med Internet Res. 2016 19;18(1):e15. [I.F. 4.532]
28. Mantarro S, Rossi M, Bonifazi M, D'Amico R, Blandizzi C, La Vecchia C, Negri E, Moja L. Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer. Intern Emerg Med. 2016;11(1):123-40. [I.F. 2.340]
29. Rossi M, Carioli G, Bonifazi M, Zambelli A, Franchi M, Moja L, Zambon A, Corrao G, La Vecchia C, Zocchetti C, Negri E. Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival. Eur J Cancer. 2016;52:41-9. [I.F. 6.163]
30. Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group. Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2016; 27(1):209. [I.F. 9.269]
31. World Health Organization. The selection and use of essential medicines: Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children).WHO technical report series ; no. 994. World Health Organization. 2015. ISBN 978 92 4 120994 6
32. Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco- Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira- González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B, Briel M. Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study. Crit Care Med. 2015;44(1):130-7. [I.F. 7.422]
33. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper extremities in people with stroke. Cochrane Database Syst Rev. 2015 Oct 8;10:CD004433. [I.F. 6.103]
13 34. Stegert M, Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Briel M; DISCO study group. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. J Clin Epidemiol. 2015;69:152-60. [I.F. 4.703]
35. Magrini N, Robertson J, Forte G, Cappello B, Moja LP, de Joncheere K, Kieny MP. Tough decisions on essential medicines in 2015. Bull World Health Organ. 2015;1;93(4):283-4. [I.F. 5.296]
36. Monticone M, Ambrosini E, Cedraschi C, Rocca B, Fiorentini R, Restelli M, Gianola S, Ferrante S, Zanoli G, Moja L. Cognitive-behavioral Treatment for Subacute and Chronic Neck Pain: A Cochrane Review. Spine (Phila Pa 1976). 2015;40(19):1495-504. [I.F. 2.439]
37. Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Amstutz A, Briel M, Kasenda B; DISCO study group. Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2015;26(9):1966-73. [I.F. 9.269]
38. O'Donnell CP, Bruschettini M, Davis PG, Morley CJ, Moja L, Calevo MG, Zappettini S. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Cochrane Database Syst Rev. 2015;1;7:CD004953. [I.F. 6.103]
39. Morgano GP, Davoli M, Moja L, Amato L, Ferroni E, Tirani M. [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise]. Recenti Prog Med. 2015 Jun;106(6):249-79.
40. Monticone M, Cedraschi C, Ambrosini E, Rocca B, Fiorentini R, Restelli M, Gianola S, Ferrante S, Zanoli G, Moja L. Cognitive-behavioural treatment for subacute and chronic neck pain. Cochrane Database Syst Rev. 2015;26;5:CD010664. [I.F. 6.103]
41. Liberati EG, Galuppo L, Gorli M, Maraldi M, Ruggiero F, Capobussi M, Banzi R, Kwag K, Scaratti G, Nanni O, Ruggieri P, Polo Friz H, Cimminiello C, Bosio M, Mangia M, Moja L. [Barriers and facilitators to the implementation of computerized decision support systems in Italian hospitals: a grounded theory study]. Recenti Prog Med. 2015;106(4):180-91.
42. Bonovas S, Moja L, Danese S. In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution. Gastroenterology. 2015 Jun;148(7):1483-4. [I.F. 18.187]
43. Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Cochrane Database Syst Rev. 2015;1;5:CD011681. [I.F. 6.103]
44. Danese S, Fiorino G, Mary JY, Lakatos PL, D'Haens G, Moja L, D'Hoore A, Panes J, Reinisch W, Sandborn WJ, Travis SP, Vermeire S, Peyrin-Biroulet L, Colombel JF. Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative. J Crohns Colitis. 2015;9(8):601-6. [I.F. 6.585]
45. Moja L, Danese S, Fiorino G, Del Giovane C, Bonovas S. Systematic review with network meta- analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease. Aliment Pharmacol Ther. 2015;41(11):1055-65. [I.F. 6.320]
14 46. Liberati EG, Gorli M, Moja L, Galuppo L, Ripamonti S, Scaratti G. Exploring the practice of patient centered care: The role of ethnography and reflexivity. Soc Sci Med. 2015;133:45-52. [I.F. 2.814]
47. Agostini M, Moja L, Banzi R, Pistotti V, Tonin P, Venneri A, Turolla A. Telerehabilitation and recovery of motor function: a systematic review and meta-analysis. J Telemed Telecare. 2015;21(4):202-13. [I.F. 1.377]
48. Moja L, Kwag KH. Point of care information services: a platform for self-directed continuing medical education for front line decision makers. Postgrad Med J. 2015 Feb;91(1072):83-91. doi: 10.1136/postgradmedj-2014-132965. Review. PubMed PMID: 25655251; PubMed Central PMCID: PMC4345919. [I.F. 1.633]
49. Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid! …and systematic. Syst Rev. 2015;14;4:4.
50. Castellini G, Gianola S, Banzi R, Corbetta D, Gatti R, Sirtori V, Gluud C, Moja L. Constraint- induced movement therapy: trial sequential analysis applied to Cochrane collaboration systematic review results. Trials. 2014; 26;15:512. [I.F. 1.731]
51. González-Lorenzo M, Piatti A, Coppola L, Gramegna M, Demicheli V, Melegaro A, Tirani M, Parmelli E, Auxilia F, Moja L; Vaccine Decision Group. Conceptual frameworks and key dimensions to support coverage decisions for vaccines. Vaccine. 2015;25;33(9):1206-17. [I.F. 3.413]
52. Lucenteforte E, Moja L, Pecoraro V, Conti AA, Conti A, Crudeli E, Galli A, Gensini GF, Minnelli M, Mugelli A, Proietti R, Shtylla J, D'Amico R, Parmelli E, Virgili G. Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review. J Clin Epidemiol. 2015;68(3):246-56. [I.F. 4.703]
53. Negri E, Zambelli A, Franchi M, Rossi M, Bonifazi M, Corrao G, Moja L, Zocchetti C, La Vecchia C. Effectiveness of trastuzumab in first-line HER2+ metastatic breast cancer after failure in adjuvant setting: a controlled cohort study. Oncologist. 2014;19(12):1209-15. [I.F. 4.865]
54. Moja L, Kwag KH, Lytras T, Bertizzolo L, Brandt L, Pecoraro V, Rigon G, Vaona A, Ruggiero F, Mangia M, Iorio A, Kunnamo I, Bonovas S. Effectiveness of Computerized Decision Support Systems Linked to Electronic Health Records: A Systematic Review and Meta-Analysis. Am J Public Health. 2014 16:e1-e11. [I.F. 4.229]
55. Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014 9:CD011230. [I.F. 5.939]
56. Moja L, Liberati E, Galuppo L, Gorli M, Maraldi M, Nanni O, Rigon G, Ruggieri P, Ruggiero F, Scaratti G, Vaona A, Kwag K. Barriers and facilitators to the uptake of computerized clinical decision support systems in specialty hospitals: protocol for a qualitative cross-sectional study. Implement Sci. 2014; 9(1):105. [I.F. 3.470]
15 57. Pecoraro V, Moja L, Dall'Olmo L, Cappellini G, Garattini S. Most appropriate animal models to study the efficacy of statins: a systematic review. Eur J Clin Invest. 2014;44(9):848-71. [I.F. 2.834]
58. Santesso N, Rader T, Nilsen ES, Glenton C, Rosenbaum S, Ciapponi A, Moja L, Pardo JP, Zhou Q, Schünemann HJ. A summary to communicate evidence from systematic reviews to the public improved understanding and accessibility of information: a randomized controlled trial. J Clin Epidemiol. 2014:S0895-4356(14)00213-3. [I.F. 5.478]
59. Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco- Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ. 2014;349:g4539. [I.F. 16.378]
60. Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B,Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study. Ann Surg. 2014;262(1):68-73. [I.F. 7.188]
61. Bonifazi M, Franchi M, Rossi M, Zambelli A, Moja L, Zambon A, Corrao G, La Vecchia C, Zocchetti C, Negri E. Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: A large cohort study from clinical practice. Breast. 2014;(5):573-8. [I.F. 2.581]
62. Balduzzi S, Mantarro S, Guarneri V, Tagliabue L, Pistotti V, Moja L, D'Amico R. Trastuzumab- containing regimens for metastatic breast cancer. Cochrane Database Syst Rev. 2014;6:CD006242. [I.F. 5.939]
63. Moja L, Pecoraro V, Ciccolallo L, Dall'Olmo L, Virgili G, Garattini S. Flaws in animal studies exploring statins and impact on meta-analysis. Eur J Clin Invest. 2014;44(6):597-612. [I.F. 2.834]
64. Danese S, Fiorino G, Peyrin-Biroulet L, Lucenteforte E, Virgili G, Moja L, Bonovas S. Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta- analysis. Ann Intern Med. 2014;160(10):704-11. [I.F. 16.104]
65. Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Prevalence, characteristics, and publication of discontinued randomized trials. JAMA. 2014;311(10):1045-51. [I.F. 30.387]
66. Morici N, Moja L, Rosato V, Sacco A, Mafrici A, Klugmann S, D’Urbano M, La Vecchia C, De Servi S, Savonitto S. Bridge with intravenous antiplatelet therapy during temporary withdrawal
16 of oral agents for surgical procedures: A systematic review. Internal and Emergency Medicine. 2014;9(2):225-35. [I.F. 2.345]
67. Prutsky GJ, Domecq JP, Erwin PJ, Briel M, Montori VM, Akl EA, Meerpohl JJ, Bassler D, Schandelmaier S, Walter SD, Zhou Q, Coello PA, Moja L, Walter M, Thorlund K, Glasziou P, Kunz R, Ferreira-Gonzalez I, Busse J, Sun X, Kristiansen A, Kasenda B, Qasim-Agha O, Pagano G, Pardo-Hernandez H, Urrutia G, Murad MH, Guyatt G. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design. Trials. 2013;14(1):335. [I.F. 2.117]
68. Gianola S, Pecoraro V, Lambiase S, Gatti R, Banfi G, Moja L. Efficacy of muscle exercise in patients with muscular dystrophy: a systematic review showing a missed opportunity to improve outcomes. PLoS One. 2013;8(6):e65414. [I.F. 3.534]
69. Bonifazi M, Franchi M, Rossi M, Moja L, Zambelli A, Zambon A, Corrao G, La Vecchia C, Zocchetti C, Negri E. Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study. Oncologist. 2013;18(7):795-801. [I.F. 4.540]
70. Bonifazi M, Zuccatosta L, Trisolini R, Moja L, Gasparini S. Transbronchial needle aspiration: a systematic review on predictors of a successful aspirate. Respiration. 2013;86(2):123-34. [I.F. 2.924]
71. Gianola S, Gasparini M, Agostini M, Castellini G, Corbetta D, Gozzer P, Li LC, Sirtori V, Taricco M, Tetzlaff JM, Turolla A, Moher D, Moja L. Survey of the reporting characteristics of systematic reviews in rehabilitation. Physical Therapy. 2013;93(11):1456-66. [I.F. 3.245]
72. Proietti R, Pecoraro V, Di Biase L, Natale A, Santangeli P, Viecca M, Sagone A, Galli A, Moja L, Tagliabue L. Remote magnetic with open-irrigated catheter vs. manual navigation for ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2013; 15(9):1241-8. [I.F. 3.050]
73. Morici N, Moja L, Rosato V, Oreglia JA, Sacco A, De Marco F, Bruschi G, Klugmann S, La Vecchia C, Savonitto S. Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: Meta-analysis and meta- regression. International Journal of Cardiology. 2013; 168(3):1955-64. [I.F. 6.175]
74. Rengo G, Pagano G, Squizzato A, Moja L, Femminella GD, de Lucia C, Komici K, Parisi V, Savarese G, Ferrara N, Perrone-Filardi P, Leosco D. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. PLoS One. 2013;8(1):e52952. doi:10.1371/journal.pone.0052952. [I.F. 3.534]
75. Moja L, Piatti A, Pecoraro V, Ricci C, Virgili G, Salanti G, Germagnoli L, Liberati A, Banfi G. Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS One. 2012;7(10):e46175. [I.F. 4.092]
76. Arezzo A, Vettoretto N, Famiglietti F, Moja L, Morino M. Laparoendoscopic rendezvous reduces perioperative morbidity and risk of pancreatitis. Surgical Endoscopy and other interventional techniques. 2012;27(4):1055-60. [I.F. 3.427]
77. Moja L, Fernandez del Rio MP, Banzi R, Cusi C, D'Amico R, Liberati A, Lodi G, Lucenteforte E, Minozzi S, Pecoraro V, Virgili G, Parmelli E. Multiple systematic reviews: methods for
17 assessing discordances of results. Internal and Emergency Medicine. 2012;7(6):563-8. [I.F. 2.345]
78. Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, Guarneri V, D'Amico R. Trastuzumab containing regimens for early breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006243. [I.F. 5.785]
79. Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, La Vecchia C. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta- analysis. Epidemiology. 2012;23(3):402-14. [I.F. 5.738]
80. Colombo C, Moja L, Gonzalez-Lorenzo M, Liberati A, Mosconi P. Patient empowerment as a component of health system reforms: rights, benefits and vested interests. Internal and Emergency Medicine. 2012;7(2):183-7. [I.F. 2.345]
81. Bonifazi M, Rossi M, Moja L, Scigliano VD, Franchi M, La Vecchia C, Zocchetti C, Negri E. Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety. Oncologist. 2012;17(1):117-24. [I.F. 4.095]
82. Squizzato A, Moja L, Ricci S, Gensini GF. Diagnosing acute stroke with magnetic resonance imaging (MRI) calls for caution: computed tomography (CT) is preferable for standard care. Internal and Emergency Medicine. 2012;7(1):71-3. [I.F. 2.345]
83. Erba G, Moja L, Beghi E, Messina P, Pupillo E. Barriers toward epilepsy surgery. A survey among practicing neurologists. Epilepsia. 2012; 53(1):35-43. [I.F. 3.909]
84. Banzi R, Cinquini M, Liberati A, Moschetti I, Pecoraro V, Tagliabue L, Moja L. Speed of updating online evidence based point of care summaries: prospective cohort analysis. BMJ. 2011;343:d5856. doi: 10.1136/bmj.d5856. [I.F. 13.471]
85. Banzi R, Moja L, Pistotti V, Facchini A, Liberati A. Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews. Health Research Policy and Systems. 2011; 9(1):26. [I.F. -]
86. Moja L, Banzi R. Navigators for medicine: evolution of online point-of-care evidence-based services. International Journal of Clinical Practice. 2011; 65(1):6-11. [I.F. 2.309]
87. Parmelli E, Papini D, Moja L, Bandieri E, Belfiglio M, Ciccone G, De Palma R, Leoni M, Longo G, Magrini N, Moschetti I, Liberati A. Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Annals of Oncology. 2011; 22(1):188-94. [I.F. 6.452]
88. Corbetta D, Sirtori V, Moja L, Gatti R. Constraint-induced movement therapy in stroke patients: systematic review and meta-analysis. European Journal Physical Rehabilitation Medicine. 2010 Dec;46(4):537-44. [I.F. 2.246]
89. Banzi R, Liberati A, Moschetti I, Tagliabue L, Moja L. A review of online evidence-based practice point-of-care information summary providers. Journal of Medical Internet Research. 2010; 12(3):e26. [I.F. 4.663]
18 90. Banzi R, Moja L, Pistotti V, Facchini A, Liberati A. Valutazione dell’impatto della ricerca biomedica e sanitaria: revisione sistematica di letteratura. Politiche Sanitarie. 2010; 11(3): 221- 41.
91. Italian Medicines Agency (AIFA) Research & Development Working Group. Feasibility and challenges of independent research on drugs: the Italian Medicines Agency (AIFA) experience. European Journal of Clinical Investigation 2010; 40(1):69-86. [I.F. 2.736]
92. Baldo P, Rupolo M, Compagnoni A, Lazzarini R, Bearz A, Cannizzaro R, Spazzapan S, Truccolo I, Moja L. Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD004629. DOI: 10.1002/14651858.CD004629. [I.F. 6.186]
93. Moja L. Clinical trials: trial registration cannot alone transform scientific conduct. Nature Urology 2009. 7(1):7-8. [I.F. 2.615 - Nature Reviews Urology was previously published as Nature Clinical Practice Urology]
94. Amato B, Moja L, Panico S, Persico G, Rispoli C, Rocco N, Moschetti I. Shouldice technique versus other open techniques for inguinal hernia repair. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001543. DOI: 10.1002/14651858.CD001543.pub3. [I.F. 5.653]
95. Sirtori V, Corbetta D, Moja L, Gatti R. Constraint-induced movement therapy for upper extremities in stroke patients. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD004433. DOI: 10.1002/14651858.CD004433.pub2.[I.F. 5.653]
96. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche P, et al. The Prisma Group (Moja L). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Annals of Internal Medicine 2009, 151(4): w65-w94.[I.F. 16.225]
97. Moher D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group (Moja L). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine 2009, 6: e1000097. doi:10.1371/journal.pmed. e1000097.[I.F. 13.050]
98. Moja LP, Moschetti I, Nurbhai M, Compagnoni A, Liberati A, Grimshaw JM, Chan AW, Dickersin K, Krleza-Jeric K, Sim I, Volmink J. Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials 2009, 10:56. [I.F. 2.020]
99. Li LC, Moja L, Romero A, Sayre EC, Grimshaw JM. Nonrandomized quality improvement trials might overstate the strength of causal inference of their findings. Journal of clinical epidemiology 2009. 62(9):959-66. [I.F. 2.956]
100. Moja L, Moschetti I, Cinquini M, Sala V, Compagnoni A, Duca P, Deligant C, Manfrini R, Clivio L, Satolli A, Addis A, Grimshaw J, Dri P, Liberati A. Clinical Evidence Continuous Medical Education: a randomised educational trial of an open access e-learning program for transferring evidence-based information - ICEKUBE (Italian Clinical Evidence Knowledge Utilization Behaviour Evaluation) - Study protocol. Implementation Science 2008, 3:37 doi:10.1186/1748-5908-3-37 [I.F. -]
19 101. De Andrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Annals of Oncology 2008, 19(12): 1985-91 doi:10.1093/annonc/mdn419 [I.F. 4.935]
102. Moja L, Moschetti I, Liberati A, Manfrini R, Deligant C, Satolli R, Addis A, Martini N, Dri P. Using Clinical Evidence in a national continuing medical education program in Italy. PLoS Medicine 2007. 4(5): e113. doi:10.1371/journal.pmed.0040113 [I.F. 12.601]
103. Moja PL, Castelli B, McCauley L, Grilli R, Auxilia F. Cochrane EPOC Group: closing the gap between quality assurance and organization of care research and front line professionals. Annali di Igiene 2005;17(6): 585-590. [I.F. -]
104. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD002919. DOI: 10.1002/14651858.CD002919.pub2. [I.F. -]
105. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. British Medical Journal 2005;330(7499):1053-1055. [I.F. 9.052]
106. Moja PL, Albanese E, Centurione E, Auxilia F. Communicating with patients: how good are our pamphlets and other written materials? An evaluation of the quality of the written information available to patients with asthma and diabetes in out-patients' clinics in Milan. Annali di Igiene 2004;16(3):509-17. [I.F. -]
107. Formoso G, Moja L, Nonino F, Dri P, Addis A, Martini N, Liberati A. Clinical Evidence: a useful tool for promoting evidence based medicine? BMC Health Services Research 2003;3:24. [I.F.0.676]
108. Moja PL, Lari C, Trisolini R, Auxilia F. Analysis of some variables concerning guidelines adopted in a Hospital in Milan: quantity, quality and physicians’ attitude. Which is the reciprocal influence of these factors? European Journal of Public Health 2003;13(2):146-51. [I.F.1.281]
Other reports, commissions, exhibitions and clinical vignettes
1. Moja L. Stridor at night. Evidence-Based Child Health: A Cochrane Review Journal. 2011; 6(1): 4-6 (Answers: 276).
2. Moja L. Chronic cough: a natural (and parental) disaster. Evidence-Based Child Health: A Cochrane Review Journal. 2010; 5(4): 1552-1554 (Answers: 2007).
3. Moja L. Anxiety above the clouds. Evidence-Based Child Health: A Cochrane Review Journal. 2010; 5(3): 1192–1195 (Answers 1547).
4. Dall'olmo L, Moja L. Treatment for non-dysplastic Barrett's oesophagus: a well-informed, demanding patient. Internal and Emergency Medicine 2010; 5(5):433-5 [I.F. 2.139]
5. Macura A, Abraha I, Kirkham J, Gensini GF, Moja L, Iorio A. Selective outcome reporting: telling and detecting true lies. The state of the science. Internal and Emergency Medicine 2010; 5(2):151-5. [I.F. 2.139]
20 6. Sirtori V, Corbetta D, Moja L, Gatti R. Constraint-induced movement therapy for upper extremities in patients with stroke. Stroke 2010;41:e57-e58. [I.F. 5.756]
7. Banzi R, Moja L, Liberati A, Gensini GF, Gusinu R, Conti AA. Measuring the impact of evidence: the Cochrane systematic review of organised stroke care. Internal and Emergency Medicine 2009; 4:507–510. [I.F. 2.371]
8. Virgili G, Conti AA, Moja L, Gensini GF, Gusinu R. Heterogeneity and meta-analyses: do study results truly differ? Internal and Emergency Medicine 2009; 4:423–427. [I.F. 2.371]
9. Squizzato A, Moja L, Gensini GF, Gusinu R, Conti AA. Is thrombolisis for intermediate-risk pulmonary embolism beneficial? The case of Emeritus Professor Crow. Internal and Emergency Medicine 2009; 4:339-41. [I.F. 2.371]
10. Puljak L, Moja L, Gensini GF, Gusinu R, Conti AA. Commercial dressings for burns versus sweet ancient remedy. Internal and Emergency Medicine 2009; 4(1):53-6. [I.F. 2.371]
11. Filippini G, Moja L, Liberati A, Gensini GF, Gusinu R, Conti AA. When drug companies select what they want to publish patients are denied relevant therapeutic information. Internal and Emergency Medicine 2008; 3(3):255-7.
12. Iorio A, Moja L, Liberati A, Gensini GF, Gusinu R, Conti AA. Selecting references that match constructs: the difficult job of citing the parachute hyperbole. Internal and Emergency Medicine 2008; 3(2):151-4.
13. Banzi R, Moja L, Moschetti I, Liberati A, Gensini GF, Gusinu R, Conti AA. Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing. Internal and Emergency Medicine 2008; 3(1):53-6.
14. Moja L, Virgili G, Liberati A, Gusinu R, Gensini GF, Conti AA. Scales to climb borderline personalities: when science goes nowhere. Internal and Emergency Medicine 2007; 2(4):315-7.
15. Moja L, Minozzi S, Liberati A, Gusinu R, Gensini GF. The drama of cancer pain: when the research abandons patients and reason. Internal and Emergency Medicine 2007; 2(3):226-8.
16. Moja L, Moschetti I, Liberati A, Gensini GF, Gusinu R. Understanding systematic reviews: the meta-analysis graph (also called 'forest plot'). Internal and Emergency Medicine 2007; 2(2):140- 2.
17. Moja L, Moschetti I, Liberati A, Gensini GF, Gusinu R. Systematic reviews highlight the complex balance between good and harm from screening studies. Internal and Emergency Medicine 2007; 2(1):57-59.
18. Liberati A, Moja L, Moschetti I. Quali prove di efficacia per quali decisioni? Neurological Science 2006; 27:S1-S5. [I.F. 0.894]
19. Moja L, Moschetti I, Liberati A, Gensini GF. Renaissance of a res publica clinical research: global access to trial registers. Internal and Emergency Medicine 2006; 1(4):310-311.
20. Liberati A, Moja L, Moschetti I, Gensini GF, Gusinu R. Human albumin solution for resuscitation and volume expansion in critically ill patients. Internal and Emergency Medicine 2006; 1(3):243-245.
21
21. Liberati A, Moja LP, Moschetti I. The future of clinical research: why do we need an ecological approach? Recenti progressi in medicina 2006; 97(11):604-610.
Letters
1. Bonovas S, Moja L, Danese S. In the presence of conceptual heterogeneity, results of network meta-analysis comparing therapies in Crohn's Disease need to be interpreted with caution. Gastroenterology. 2015;148(7):1483-4.
2. Morici N, Moja L, Rosato V, Savonitto S. Reply to letter to the editor: "adenosine di-phosphate receptor antagonist discontinuation management prior to coronary artery surgery". Int J Cardiol. 2014 Mar 1;172(1):221-2.
3. Moja L, Banzi R, Tagliabue L. Review of "pull" point-of-care services. International Journal of Medical Informatics. 2011; 80(8):604-5. [I.F. 2.244]
4. Banzi R, Liberati A, Moschetti I, Tagliabue L, Moja L. Review of Online Evidence-based Practice Point-of-Care Information Summary Providers: Authors' Reply to the Response by the Publisher of DynaMed. Journal of Medical Internet Research. 2010; 12(3):e40. [I.F. 4.663]
5. Liberati A, Davoli M, Filippini G, Moja L. Comment to "Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision making?" Digestive and Liver Disease 2010; 42(10):746. [I.F. 2.805]
6. Banzi R, Moschetti I, Moja L. Internet-based education for health professionals. JAMA 2009 301(6): 599-600. [I.F. 28.899]
7. Moja L, Moschetti I, D’Amico R. Outcome reporting bias in RCTs funded by the government: a call for further investigations. Canadian Medical Association Journal 2005; 172(7): 857. [I.F. 7.402]
Non-refereed publications
1. Liberati E, Moja L. L’ospedale centrato sul paziente è ancora lontano. Ricerca e pratica 2014; 30(4):4-11.
2. De Palma R, Liberati A, Papini D, Bandieri E, Belfiglio M, Ceccarelli M, Ciccone G, Leoni M, Longo G, Magrini N, Moja LP, Moschetti I, Parmelli E, Roila F. La produzione di raccomandazioni cliniche con il metodo GRADE: l’esperienza sui farmaci oncologici. Dossier 172-2009, Agenzia Sanitaria e Sociale Regionale, Regione Emilia Romagna.
3. Moja L, et al. Il progetto ECCE - Clinical Evidence: i risultati di due anni di sperimentazione. In: Bacchielli MP, Bellotti F, Biocca M, Cavallo M, Innorta M, et al. Per un Osservatorio nazionale sulla qualità dell’Educazione continua in medicina. Dossier 170-2008, Agenzia Sanitaria e Sociale Regionale, Regione Emilia Romagna.
4. Moja L. L’Ottawa Statement: principi per la registrazione degli studi clinici. Medicina Italia 2007; Novembre 1/07.
22 5. Deligant C, Di Giulio P, Dri P, Liberati A, Manfrini R, Moschetti I, Moja L, Satolli R. Il Progetto ECCE tocca quota ottantamila: le esperienze di medici e infermieri in parallelo. Bollettino d’Informazione sui Farmaci 2007; 1(XIV):3-7. [ECCE touches 80000 users: doctors and nurses in parallel]
6. Deligant C, Dri P, Liberati A, Manfrini R, Moschetti I, Moja L, Satolli R. Il Progetto ECCE: i risultati di un modello di formazione a distanza orientato sul caso clinico. Bollettino d’Informazione sui Farmaci 2006; 1(XIII):10-18. [ECCE: results of one year experimental project for distance learning using clinical vignettes]
7. Moschetti I, Moja L, Dri P, Manfrini R, Satolli R, Deligant C, Liberati A. La formazione permanente in Italia, il possibile ruolo delle evidence based medicine: qualcosa si muove. Clinical Evidence ed ECCE. Ricerca e pratica 2005; 21:188-198. [Continuing education in Italy, evidence based medicine’s possible role: something is moving. Clinical evidence and ECCE].
8. Moja L, Moschetti I, Ballini L, Deligant C, Manfrini R, Satolli R, Dri P, Liberati A. Progetto sperimentale ECCE per la formazione a distanza del medico. Bollettino d’Informazione sui Farmaci 2005; 1(XII):13-19. [ECCE: an experimental project for distance medical education].
9. Moja L, Santesso N, Palmhoj C, Grimshaw J. Feeding tubes and cultural shift: strong causal inference from weak study design. British Medical Journal [rapid response on internet]. 2004 Sept [cited 2004 Dic 6]. Available from: http://bmj.bmjjournals.com/cgi/eletters/329/7464/491#73892
10. Formoso G, Moja L, Nonino F, Dri P, Liberati A. Clinical Evidence: un utile supporto informativo per i medici? I risultati di uno studio realizzato in dieci regioni italiane. Bollettino d’Informazione sui Farmaci 2003; 3-4(X):138-142. [Clinical Evidence: a useful tool to improve medical knowledge? Hints from the pilot distribution of Clinical Evidence in ten Italian regions].
11. Moja PL. Analisi di alcune variabili riguardanti le linee-guida adottate in un ospedale universitario di Milano: valutazione del loro numero, della tipologia e qualità e dell’atteggiamento dei medici. Quale influenza reciproca hanno questi fattori? Panorama della Sanità 2002; 6:40-43. [Analysis of some variables concerning guidelines adopted in a Hospital in Milan: quantity, quality and physicians’ attitude. Which is the reciprocal influence of these factors?].
12. Lunardelli M, Moja L. Un luogo di incontro per gli studenti di medicina. Medico Domani (Periodico di informazione per gli studenti in medicina) 2000; 1(1):3.
Books and reviews
1. The selection and use of essential medicines. Report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization; 2015 (WHO Technical Report Series, No. 994; http://apps.who.int/iris/bitstream/10665/189763/1/9789241209946_eng.pdf ).
2. Moja L. Medici e omeopatia: qualche numero. In: Garattini S (a cura di). Acqua fresca? Tutto quello che bisogna sapere sull'omeopatia. 2015 Sironi, pp. 137-50 [ISBN: 978-8851802486]
23 3. Moja L, Alessandrini I. Medicina narrativa e medicina basata sulle evidenze. In: Marini MG, Arreghini L, editors. Medicina narrativa per una sanità sostenibile. 2012 Lupetti – Editori di comunicazione, pp.3-11 [ISBN: 978-88-8391-373-0].
4. Clinical Evidence edizione italiana, VI edizione. 2008 Zadig, Milano. [Italian translation and adaptation of Clinical Evidence, BMJ Publishing Group, London].
5. Liberati A, Moja LP, Moschetti I. Evidence-based medicine: its contribution in the way we search, appraise and apply scientific information to patient care. In: Candelise L, Hughes R, Liberati A, Uitdehaag MJ, Warlow C, editors. Evidence-based neurology. Management of neurological disorders. 2007 BMJ Books, pp.3-11 [ISBN: 978-0-7279-1811-6].
6. Clinical Evidence edizione italiana, V edizione. 2007 Zadig, Milano. [Italian translation and adaptation of Clinical Evidence, BMJ Publishing Group, London].
7. Clinical Evidence edizione italiana, IV edizione. 2006 Zadig, Milano. [Italian translation and adaptation of Clinical Evidence, BMJ Publishing Group, London].
8. D'Amico R, Moja L, Liberati A. La sintesi dei risultati della ricerca: revisioni e meta-analisi. In: Faggiano F, Donato F, Barbone F, editors. Manuale di epidemiologia per la sanità pubblica. Torino: Centro Scientifico Editore, 2005, pp.309-333. [Synthesizing results of research: systematic reviews and meta-analyses].
9. Clinical Evidence edizione italiana, III edizione. 2005 Zadig, Milano. [Italian translation and adaptation of Clinical Evidence, BMJ Publishing Group, London].
10. Candelise L, Moja PL. Qualità delle risorse e prestazioni sanitarie per la cura del paziente ricoverato per ictus cerebrale acuto. In: Istituto Auxologico Italiano editor. Rapporto sull'ictus Milano: Masson, 2004, pp.11-26. [Quality resources and health care services for acute stroke patients].
11. Clinical Evidence edizione italiana, II edizione. 2003 Zadig, Milano. [Italian translation and adaptation of Clinical Evidence, BMJ Publishing Group, London].
Protocols
1. Rossi RE, Pozzi R, Gonzalez-Lorenzo M, Kwag KH, Conte D, Cecco S, Banzi R, Moja L, Baldo P. Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adults (Protocol). Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD011568. DOI: 10.1002/14651858.CD011568.
2. Rocco N, Rispoli C, Moja L, Amato B, Iannone L, Testa S, Spano A, Catanuto G, Accurso A, Nava MB. Different types of implants for reconstructive breast surgery (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010895. DOI: 10.1002/14651858.CD010895.
3. Savino F, Tarasco V, Sorrenti M, Lingua C, Moja L, Gordon M, Biagioli E. Dietary modifications for infantile colic (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011029. DOI: 10.1002/14651858.CD011029.
24 4. Vettoretto N, Arezzo A, Famiglietti F, Cirocchi R, Moja L, Morino M. Laparoscopic-endoscopic rendezvous versus preoperative endoscopic sphincterotomy for common bile duct stones in patients undergoing laparoscopic cholecystectomy (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010507. DOI: 10.1002/14651858.CD010507.
5. Vaona A, Rigon G, Banzi R, Kwag KH, Cereda D, Pecoraro V, Moja L, Bonovas S. E-learning for health professionals (Protocol). Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD011736. DOI: 10.1002/14651858.CD011736.
6. Savino F, Tarasco V, Lingua C, Moja L, Ricceri F. Pain-relieving agents for infant colic (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009999. DOI: 10.1002/14651858.CD009999.
7. Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients (ONCO-CODES). ClinicalTrials.gov Identifier: NCT02645357 https://clinicaltrials.gov/ct2/show/NCT02645357?term=codes&recr=Recruiting&type=Intr&int r=computer&rank=1
8. Computerized Decision Support System Linked to Electronic Health Records to Improve Patient Care in a General Hospital (CODES). ClinicalTrials.gov Identifier: NCT02577198 https://clinicaltrials.gov/ct2/show/NCT02577198?term=Implementing+an+Evidence- based+Computerized+Decision+Support+System+Linked+to+Electronic+Health+Records&rec r=Recruiting&type=Intr&rank=2
9. A Device for Screening of Fall Risk in the Elderly. ClinicalTrials.gov Identifier: NCT02655796 https://clinicaltrials.gov/ct2/show/NCT02655796?locn=galeazzi&rank=4
Oral Presentations, papers posters presented at international meetings (published)
Dr Moja (co)-authored possibly more abstracts than scientific articles, as abstracts often represent embryonic forms of articles. Abstracts were included in proceedings of international meetings, presented as posters or oral presentations. He stopped tracking detailed records of abstracts in 2013.
1. Moja L, Ueffing E, Linklater S, Moayyedi P, Schaafsma ME, Tugwell P, Grimshaw J. ‘Dr Cochrane’: an innovative approach to continuing medical education using Cochrane reviews. Oral presentation at the 20th Cochrane Colloquium; 2012 Sept 30-Oct 3; Auckland, New Zealand, Cochrane Database of Systematic Reviews, Supplement 2012: No.:CD201200. PG:15-16.
2. D'Amico R, Petracci E, Balduzzi S, Moja L, Miglio R. Bias associated with selective crossover in randomised controlled trials. Poster presentation at the 20th Cochrane Colloquium; 2012 Sept 30-Oct 3; Auckland, New Zealand, Cochrane Database of Systematic Reviews, Supplement 2012: PG:44 No.:CD201200. PG:137.
3. Moja L, Banzi R, Cinquini M, Moschetti I, Pecoraro V, Tagliabue L, Liberati A. Do Cochrane reviews drive clinical decision-making at the point of care? Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain, Cochrane Database of Systematic Reviews, Supplement 2011: No.:CD000003. PG:173.
25 4. Colombo C, Pecoraro V, Banzi R, Moja L, Cima S, Mosconi P, Liberati A, Pistotti V, Spreading Cochrane press releases to lay people and Italian journalists. Oral presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain, Cochrane Database of Systematic Reviews, Supplement 2011: No.:CD000003. PG:36.
5. D'Amico R, Bonafede E, Balduzzi S, Longo G, Guarneri V, Piacentini F, Moja L, Liberati A. Unplanned crossover in randomised controlled trials: consequences for efficacy and safety outcomes. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain, Cochrane Database of Systematic Reviews, Supplement 2011: No.:CD000003. PG:137.
6. Parmelli E, Banzi R, Fernandez Del Rio MDP, Minozzi S, Moja L, Pecoraro V, Liberati A. Using AMSTAR to assess the methodological quality of systematic reviews: an external validation study. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain, Cochrane Database of Systematic Reviews, Supplement 2011: No.:CD000003. PG:139.
7. Banzi R, Liberati A, Cinquini M, Pecoraro V, Tagliabue L, Moschetti I, Moja L. Measuring update ability of evidence-based practice online point-of-care information services. Abstracts of the 18th Cochrane Colloquium, p.88. Keystone Colorado, 18-22 October 2010. Cochrane Database of Systematic Reviews, Supplement 2010: 1-166. Art No.:CD000001.DOI:10.1002/14651858.CD000002. (Poster).
8. Moja L, Banzi R, Tagliabue L, Moschetti I, Liberati A. Online evidence-based practice point of care information summaries: a content evaluation cross-sectional study. Abstracts of the 17th Cochrane Colloquium, p.15. Singapore, 11-14 October 2009. Cochrane Database of Systematic Reviews, Supplement 2009: 1-76. Art No.:CD000001.DOI:10.1002/14651858.CD000001. (Oral Presentation).
9. Parmelli E, Fernandez del Rio MdP, Minozzi S, Lodi G, Virgili G, Cusi C, Banzi R, D’Amico R, Liberati A, Moja L. Multiple and discordant systematic reviews in medical literature: an epidemiological cross sectional study across medical fields. Abstracts of the 17th Cochrane Colloquium, p.22. Singapore, 11-14 October 2009. Cochrane Database of Systematic Reviews, Supplement 2009: 1-76. Art No.:CD000001.DOI:10.1002/14651858.CD000001. (Oral Presentation).
10. Pecoraro V, Banzi R, Bidoli S, Cinquini M, Fernandez del Rio MdP, Moja L, Moschetti I, Parmelli E, Pistotti V, Liberati A. Italian Cochrane Centre training and dissemination activities. Abstracts of the 17th Cochrane Colloquium, p.30. Singapore, 11-14 October 2009. Cochrane Database of Systematic Reviews, Supplement 2009: 1-76. Art No.:CD000001.DOI:10.1002/14651858.CD000001.
11. Sala V, Moja L, Moschetti I, Pistotti V, Banzi R, Parmelli E, Cinquini M, Liberati A. Italian Cochrane Centre educational and dissemination activities. Abstracts of the 16th Cochrane Colloquium, p.40. Freiburg, Germany, 3-7 October 2008. In: Z. Evid. Fortbild. Qual. Gesundh.wesen (ZEFQ) 102(2008) S:1-106.
12. Cinquini M, Moja L, Moschetti I, Sala V, Torri V, Liberati A for the ICEKUBE Team. Predictors of evidence-based knowledge in Italian doctors. Abstracts of the 16th Cochrane Colloquium, p.52. Freiburg, Germany, 3-7 October 2008. In: Z. Evid. Fortbild. Qual. Gesundh.wesen (ZEFQ) 102(2008) S:1-106.
13. Colombo C, Moschetti I, Moja L, Mosconi P, Satolli R, Liberati A. The imperfect balance between investment and payback from presenting Cochrane reviews to lay people: the
26 PartecipaSalute experience. Abstracts of the 15th Cochrane Colloquium, p.93-4. Sao Paolo, Brasil, 23-27 October 2007 (Oral Presentation).
14. Liberati A, Moja L, Moschetti I, Pardo J. Proposal for a continuing medical education e-learning programme based on Cochrane systematic reviews (workshop). Abstracts of the 15th Cochrane Colloquium, p.93-4. Sao Paolo, Brasil, 189-190 October 2007.
15. Moja L. Linking open access to practice: promoting Clinical Evidence in a National Continuing Medical Education Program in Italy. Abstracts of the Berlin 5, p. 57. Padova, Italy, 19-21 September 2007.
16. Moschetti I, Moja L, Colombo C, Carra L, Satolli R, Mosconi P, Liberati A. How Cochrane reviews can be used in a dissemination project: preliminary findings from the “PartecipaSalute” project in Italy. Abstracts of the 14th Cochrane Colloquium, p.93. Dublin, Ireland, 23-26 October 2006.
17. Floriani I, Torri V, Rotmensz N, Martini N, de Rosa M, de Braud F, Moja L. Approaches to interim analysis of randomized clinical trials in cancer: a survey from the Italian National Monitoring Centre for Clinical Trials. Abstracts of the 14th Cochrane Colloquium, p.179. Dublin, Ireland, 23-26 October 2006.
18. Reaume N, Moja PL, Nurbhai M, McGowan, O’Rourke K, Grimshaw J, Graham I. Cumulative meta-analysis to determine key milestones in the Life Cycle of Evidence in Cancer Care (LIFE CYCLE). Abstracts of the 13th Cochrane Colloquium, p.51. Melbourne, Australia, 22-26 October 2005 (Oral Presentation).
19. McGowan J, Nurbhai M, Reaume N, Moja PL, Graham I. Bibliometric analyses along cumulative meta-analyses: the Life Cycle of Evidence in Cancer Care (LIFE CYCLE). Abstracts of the 13th Cochrane Colloquium, p.95. Melbourne, Australia, 22-26 October 2005.
20. Moschetti I, Moja PL, Steven A, Ballini L, Liberati A. Transferability of evidence based information driver by Clinical Evidence through an Italian continuing education programme on the web: a qualitative study. Abstracts of the 13th Cochrane Colloquium, p.120. Melbourne, Australia, 22-26 October 2005.
21. Li L, Moja PL, Romero A, Grimshaw J. Can we trust the conclusion in peer-review publications? A review of quality improvement intervention studies. Abstracts of the 13th Cochrane Colloquium, p.120. Melbourne, Australia, 22-26 October 2005.
22. Nurbhai M, Grimshaw J, Moja PL, Liberati A, Chan AW, Dickersin K, Krezla-Jeric K, Moher D. Assessing the quality of information recorded on trial registries. Abstracts of the 13th Cochrane Colloquium, p.165. Melbourne, Australia, 22-26 October 2005.
23. Li L, Moja PL, Romero A, Grimshaw J. “Do the conclusions look as good as they seem?” A review of quality improvement intervention studies. Abstracts of the Fifth International Congress on Peer Review and Biomedical Publication, p.47 Chicago, Illinois, 16-18 September 2005.
24. Nurbhai M, Moja PL, Grimshaw J, Liberati A, Dickersin K, Krleza-Jeric K, Moher D, Moschetti I, Rennie D, Sim I. Assessing the quality of information recorded on trial registries. Abstracts of the Fifth International Congress on Peer Review and Biomedical Publication, p.33. Chicago, Illinois, 16-18 September 2005 (Oral Presentation)
27 25. Liberati A, Addis A, Moja L, Martini N, Pistotti V, Dri P. Disseminating information on the effects of health care interventions: an Italian Ministry of Health project based on clinical evidence and its implementation for continuing medical education (CME) programme. Abstracts of the Second Health Technology Assessment International Conference, Italian Journal of Public Health; p.215. Rome, Italy, 20-22 June 2005 (Oral Presentation).
26. Li L, Romero A, Moja PL, Grimshaw J. “Do the conclusions look as good as they seem?” A review of quality improvement intervention studies. Abstracts of the 12th Cochrane Colloquium, p.153. Ottawa, Canada, 2-6 October 2004.
27. Moja PL, Nurbhai M, Reaume N, Grimshaw J, Graham I, O’Rourke K, McGowan J. Cumulative meta-analysis to determine key milestones in the Life Cycle of Evidence in Cancer Care (LIFE CYCLE-ECC). Abstracts of the 12th Cochrane Colloquium, p.167. Ottawa, Canada, 2-6 October 2004.
28. Moja P, D’Amico R, Telaro E, Battaglia A, Bianco E, Calderan A, Colli A, Ferri M, Fraquelli M, Girolami B, Marchioni E, Mezza E, Piccoli G, Vignatelli L, Monaco G, Morganti C, Franceschini R, Bermond F, Cevoli S, Franzoso F, Ruggeri M, Joppi R, Minesso E, Lomolino G, Bellù R, Liberati A (members of “Milano Master Course in Systematic Reviews”). Assessing the methodological quality of primary studies in systematic reviews: improvements are needed within and outside the Cochrane world. Abstracts of the 11th Cochrane Colloquium, p.8. Barcelona, Spain, October 26-31, 2003 (Oral Presentation).
29. Formoso G, Moja PL, Bidoli S, Liberati A. Do doctors like evidence-based information and prefer it to guidelines? Hints from the pilot distribution of Clinical Evidence (CE) within the Italian National Health Service. Abstracts of the 11th Cochrane Colloquium, p.22. Barcelona, Spain, October 26-31, 2003 (Oral Presentation).
30. Telaro E, D’Amico R, Moja P, Battaglia A, Bianco E, Calderan A, Colli A, Di Pietrantonj C, Ferri M, Fraquelli M, Girolami B, Marchioni E, Mezza E, Piccoli G, Vignatelli L, Liberati A (members of “Milano Master Course in Systematic Reviews”). Quality Assessment in Cochrane Reviews: do we practice what we preach? Abstracts of the 10th Cochrane Colloquium, pp.35-36. Stavanger, Norway, 31 July -3 August 2002.
Oral presentations, papers or posters presented at Italian meetings (published)
1. Piatti A, Pecoraro V, Germagnoli L, Moja L, Banfi G. Gestione del cambiamento attraverso le revisioni sistematiche come strumenti per orientare la pratica clinica: risultati preliminari di una collaborazione tra l’IRCCS Istituto Ortopedico Galeazzi e il Centro Cochrane Italiano (CCI). Atti del Convegno di Primavera dell’Associazione Italiana di Epidemiologia, pg. 36. Roma, 14-15 Maggio 2009.
2. Moja L, Moschetti I, Cinquini M, Sala V, Manfrini R, Deligant C, Dri R, Addis A, Liberati A. Valutazione della bontà educativa dei casi clinici di ECCE, il programma di formazione a distanza (FAD) basato sulle evidenze destinato ai medici italiani. Tutor 2008; 8(1-2): 78.
3. Moja L, Auxilia F. Il medico igienista e “ECCE” - le migliori prove di efficacia in un programma di formazione a distanza nazionale. Atti della X Conferenza Nazionale di Sanità Pubblica, p.315. Pisa, 14-16 Ottobre 2007. (Oral Presentation)
28 4. Costa E, Moja PL, Moschetti I, Nurbhai M, Grimshaw J, Rennie D, Liberati A. Valutare la qualità delle informazioni raccolte nei registri dei protocolli dei trial. Atti del XXVI Congresso Nazionale della SIFO, p.315. Catania, 19-22 Ottobre 2005.
5. Moja PL, Perenich D, Taddei A, Auxilia F. Istituto senza muri: comunicare attraverso informazioni virtuali. Atti del 40° Congresso Nazionale della SitI, p.467. Cernobbio - Como, 2002. [Institute without wall: communications by virtual informations].
6. Albanese E, Centurione E, Moja PL, Auxilia F. Comunicazione medica scritta: costruiamo informazioni di qualità per il paziente? Atti del 40° Congresso Nazionale della SitI, p.427. Cernobbio - Como, 2002. [Quality management of medical information on leaflets].
7. Castaldi S, Ferrari M, Moja PL, Sabatino G, Auxilia F, Pagano A. La prevalenza del dolore nei pazienti ospedalizzati: esperienza di una survey condotta in tre ospedali lombardi. Atti della VII Conferenza Nazionale di Sanità Pubblica, p.297. Bari, 11-13 Ottobre 2001. [Assessing the prevalence and severity of pain in three Italian hospitals].
8. Moja PL, Lari C, Spinello L, Trisolini R e Auxilia F. Studio preliminare della qualità delle linee- guida adottate ai fini dell’accreditamento istituzionale in un azienda ospedaliera milanese. Atti del 39° Congresso Nazionale della SItI, p.500-502. Ferrara, 2000. [Quality of guidelines adopted in a Hospital in Milan: preliminary results] (Oral Presentation).
Invited International and National Presentations
1. Moja L. Appropriatezza nella diagnosi precoce dei tumori: gli screening. Appropriatezza in oncologia: costa poco e fa bene. Ordine dei Medici Milano, Milano, Italy 23 February 2013. [http://policlinico.mi.it/RicercaUniversita/2013/130204Oncologia130223.pdf]
2. Moja L. I costi della non appropriatezza: quanto si può effettivamente risparmiare? Identità professionale in sanità tra spesa e qualità della cura. Assolombarda , Milano, Italy 12 May 2011. [http://www.istud.it/up_media/identita_professionale.pdf]
3. Moja L. Cochrane reviews and methodology. Excellence in Paediatrics. Florence, Italy, 3-6 December 2009.
4. Moja L. Revisioni e metanalisi: strumenti per arginare l’incertezza? L’Accademia del cittadino: valutare la qualità e la sicurezza dei servizi sanitari per fare scelte consapevoli e partecipare al miglioramento. PartecipaSalute & Regione Toscana, Milano, 23-24 November 2009. [http://www.partecipasalute.it/cms/files/Accademia_cittadino_PSalute_0.pdf]
5. Moja L. EBM and continuous medical education. International Cochrane Symposium, Copenhagen, Denmark, 22 April 2009.
6. Moja L. EBM, continuous medical education and e-learning. Bahrain Ministry of Health, Manama, Bahrain, 2 August 2008.
7. Moja L. Linking open access to practice: promoting clinical evidence in a national continuing medical education program in Italy. Berlin 5 Open Access: From practice to impact Consequence of knowledge dissemination. Verona, Italy, 19-21 September 2007.
29 Invited National Presentations
1. FAD. Il Progetto ECCE. 2a Conferenza Nazionale GIMBE Dall'Evidence-based Practice alla Clinical Governance. Bologna. 9 February 2007.
2. Sistemi di valutazione, competenze, organizzazione e conflitti di interesse nella formazione continua in sanità. La qualità nella formazione continua in medicina. Bologna, Italy, 21-22 May 2007.
3. Cosa dicono e cosa non dicono le storie. Seminari dell’appropriatezza. Eccellenza. Fare di più o fare meglio? Ospedale S. Croce, Cuneo. 23 October 2014.
Editorial responsibilities
Deputy-editor to the Internal and Emergency Medicine, Journal of the Italian Internal Medicine Society, 2007 to present.
Peer review
Peer reviewer for: American Journal of Public Health Annals of Oncology BMC Medical Research Methodology BMJ British Medical Journal BMJ Open Cochrane Effective Practice and Organisation of Care Group European Journal of Neurology Internal and Emergency Medicine JAMA Journal of American Medical Association Journal of Clinical Epidemiology JMIR Medical Informatics Journal of Medical Internet Research Health and Quality of Life Outcomes PLOS One PLOS Medicine
International Conference committees
Organizer of the International Scientific Program Committee for the International Clinical Trials’ Day Fourth Edition, ‘Disease and promotion of public awareness: the role of evidence from clinical trials’, Milan, 20 May 2009.
Continental European Cochrane Entities Meeting (CECEM) of the Cochrane Collaboration, Milan, Italy, 7-8 May 2008.
Member of the abstracts committee for the XVI Cochrane Colloquium, 'Evidence in the era of globalisation', The Cochrane Collaboration, Freiburg, Germany, October 2008.
30 Organizer of the International Scientific Program Committee for the Continental European Cochrane Entities Meeting (CECEM) of the Cochrane Collaboration, Milan, Italy, 7-8 May 2008.
Member of the Scientific Thomas C. Chalmers Award Committee for the XIII Cochrane Colloquium, ‘Corroboree’, The Cochrane Collaboration, Melbourne, Australia, 22-26 October 2005.
National Conference committees
Member of the Scientific Program Committee for the XII Riunione annuale network Cochrane italiano, Milano, 29-30 novembre 2007: "La trasparenza nella produzione e disseminazione delle informazioni scientifiche".
Member of the Scientific Program Committee for the XI Riunione annuale network Cochrane italiano, Roma , 28 novembre 2006: "Aree di incertezza in medicina: come identificarle e promuovere la ricerca necessaria".
Teaching
Lecturer for MSc in: Evidence-Based Medicine and Research Methodology in Health Care, Medical School, University of Modena and Reggio-Emilia, 2007 – 2008. Research Methodology, Medical School, University of Parma, 2008 - 2009. Coordinamento Infermieristico, Medical School, University of Milan, 2006 – 2009 [Coordinatori di Unità Operativa e/o di Dipartimento per le professioni infermieristiche e ostetriche]. Promotion and governance of research in health care institutes, Faculty of Medicine, University of Modena and Reggio-Emilia, 2009.
Course organizer and lecturer for Corso di Perfezionamento in: Systematic reviews, meta-analyses and guidelines – Cochrane methodology, Medical School, University of Milan, 2009 – 2010 and 2010 – 2011.
In addition, Dr Moja has been involved in various other ad hoc teaching activities, for example: Course organiser and faculty member for Systematic Reviews, Meta-Analyses and Guidelines course. IRCCS Istituto Ortopedico Galeazzi, Milan, 2008 - 2009. Course organiser and faculty member for One-day Cochrane Workshops, 2006 to 2012.
31